Brief: Quiapeg Enters Conditional Agreement On Reverse Takeover

QUIA PHARMA AB (publ)

08/11/2023 07:32

Nov 8 (Reuters) - QuiaPEG Pharmaceuticals Holding AB
 QUIA.ST :
    * QUIAPEG ENTERS CONDITIONAL AGREEMENT ON A REVERSE TAKEOVER
AND
FINANCING TO ENABLE CONTINUED BUSINESS DEVELOPMENT OF EXISTING
OPERATIONS
    * HAS ENTERED INTO CONDITIONAL AGREEMENT ON REVERSE TAKEOVER
WITH
ROSEMONKEY
    * REVERSE TAKEOVER IS PROPOSED TO BE CARRIED OUT THROUGH A
DIRECTED NEW ISSUE OF SHARES IN COMPANY TO ROSEMONKEY
    * AFTER NEW ISSUE, ROSEMONKEY WILL OWN 95 PER CENT OF ALL
OUTSTANDING SHARES IN QUIAPEG
    * WILL ISSUE 33,211,006 NEW SHARES TO LENDERS ( "LOAN
ISSUE") TO
ENSURE FULL SETTLEMENT OF LOANS
    * ROSEMONKEY ISSUES A TOTAL CASH CONSIDERATION TO QUIAPEG OF
SEK
2.6 MILLION
    * QUIAPEG ACQUIRES IPR FOR NEW BUSINESS FROM ROSEMONKEY FOR
AN
AGREED VALUE OF SEK 20 MILLION
    * ROSEMONKEY WILL RECEIVE NEW SHARES IN QUIAPEG
CORRESPONDING TO
95 PER CENT OF ALL OUTSTANDING SHARES IN COMPANY AFTER BOTH LOAN
ISSUE AND NEW ISSUE

Source text for Eikon:  ID:nMFNbBgtHp 
Further company coverage:  QUIA.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))